Literature DB >> 9412316

Laboratory evaluation in the diagnosis of Lyme disease.

P Tugwell1, D T Dennis, A Weinstein, G Wells, B Shea, G Nichol, R Hayward, R Lightfoot, P Baker, A C Steere.   

Abstract

PURPOSE: To provide a qualitative evaluation of the predictive value of the laboratory diagnosis of Lyme disease and to use the resultant data to formulate guidelines for clinical diagnosis. DATA SOURCES: A MEDLINE search of English-language articles or articles with English-language abstracts published from 1982 to 1996. DATA EXTRACTION: Sensitivity, specificity, and likelihood ratios were calculated, and a random-effects model was used to combine the proportions from the eligible studies. Prespecified criteria were used to determine which studies were eligible for analysis. DATA SYNTHESIS: Laboratory testing in general is not clinically useful if the pretest probability of Lyme disease is less than 0.20 or greater than 0.80. When the pretest probability is 0.20 to 0.80, sequential testing with enzyme-linked immunosorbent assay and Western blot is the most accurate method for ruling in or ruling out the possibility of Lyme disease.
CONCLUSIONS: Laboratory testing is recommended only in patients whose pretest probability of Lyme disease is 0.20 to 0.80. If the pretest probability is less than 0.20, testing will result in more false-positive results than true-positive results; a negative test result in this situation effectively rules out the disease.

Entities:  

Mesh:

Year:  1997        PMID: 9412316     DOI: 10.7326/0003-4819-127-12-199712150-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  62 in total

1.  Effects of OspA vaccination on Lyme disease serologic testing.

Authors:  M E Aguero-Rosenfeld; J Roberge; C A Carbonaro; J Nowakowski; R B Nadelman; G P Wormser
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

3.  Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens.

Authors:  S Bas; P Muzzin; B Ninet; J E Bornand; C Scieux; T L Vischer
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Evidence-based clinical microbiology.

Authors:  G Giocoli
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Patterns of Lyme disease diagnosis and treatment by family physicians in a southeastern state.

Authors:  John M Boltri; Robert B Hash; Robert L Vogel
Journal:  J Community Health       Date:  2002-12

6.  Chronic Meningitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

Review 7.  The emergence of Lyme disease in Canada.

Authors:  Nicholas H Ogden; L Robbin Lindsay; Muhammad Morshed; Paul N Sockett; Harvey Artsob
Journal:  CMAJ       Date:  2009-06-09       Impact factor: 8.262

8.  The Borrelia burgdorferi 37-kilodalton immunoblot band (P37) used in serodiagnosis of early lyme disease is the flaA gene product.

Authors:  R D Gilmore; R L Murphree; A M James; S A Sullivan; B J Johnson
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Appropriateness of Lyme disease serologic testing.

Authors:  Alan H Ramsey; Edward A Belongia; Po-Huang Chyou; Jeffrey P Davis
Journal:  Ann Fam Med       Date:  2004 Jul-Aug       Impact factor: 5.166

10.  BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Authors:  Adam S Coleman; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.